ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Indonesia teams with China's Sinovac for COVID vaccine

Pandemic underscores need for national self-reliance in drug R&D and production

The world's fourth-most populous country is seeking to be self-reliant in pharmaceuticals.   © Reuters

JAKARTA -- The coronavirus pandemic has energized Indonesia's drive for self-reliance in pharmaceuticals, with state-owned Bio Farma collaborating on a vaccine with China's Sinovac Biotech and a company from the United Arab Emirates.

The state-owned Indonesian company considers the tie-ups as important for future development and production of vaccines -- and even new medicines -- in the world's fourth-most populous country.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more